The DOI matches its Crossref record; 233 of the 233 references it cites were found in a registry or an index.
Systemic lupus erythematosus: Diagnosis and clinical management
Open accessAbstract
Systemic lupus erythematosus (SLE) is a worldwide chronic autoimmune disease which may affect every organ and tissue. Genetic predisposition, environmental triggers, and the hormonal milieu, interplay in disease development and activity. Clinical manifestations and the pattern of organ involvement are widely heterogenous, reflecting the complex mosaic of disrupted molecular pathways converging into the SLE clinical phenotype. The SLE complex pathogenesis involves multiple cellular components of the innate and immune systems, presence of autoantibodies and immunocomplexes, engagement of the complement system, dysregulation of several cytokines including type I interferons, and disruption of the clearance of nucleic acids after cell death. Use of immunomodulators and immunosuppression has altered the natural course of SLE. In addition, morbidity and mortality in SLE not only derive from direct immune mediated tissue damage but also from SLE and treatment associated complications such as accelerated coronary artery disease and increased infection risk. Here, we review the diagnostic approach as well as the etiopathogenetic rationale and clinical evidence for the management of SLE. This includes 1) lifestyle changes such as avoidance of ultraviolet light; 2) prevention of comorbidities including coronary artery disease, osteoporosis, infections, and drug toxicities; 3) use of immunomodulators (i.e. hydroxychloroquine and vitamin D); and 4) immunosuppressants and targeted therapy. We also review new upcoming agents and regimens currently under study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–233 of 233
Mok, C., To, C., Yu, K., & Ho, L. (2013) · Lupus · doi:10.1177/0961203313502864 · Cited by 74
Thompson, R. A., Haeney, M. R., Reid, K., Davies, J. G., White, R. H. R., & Cameron, A. (1980) · New England Journal of Medicine · doi:10.1056/nejm198007033030107 · Cited by 74
Herrinton, L. J., Liu, L., Goldfien, R. D., Michaels, M. A., & Tran, T. N. (2016) · The Journal of Rheumatology · doi:10.3899/jrheum.150671 · Cited by 73
In Vivo Models of Thrombosis for the Antiphospholipid Syndrome
Pierangeli, S., & Harris, E. N. (1996) · Lupus · doi:10.1177/096120339600500524 · Cited by 68
High prevalence of vertebral deformity in premenopausal systemic lupus erythematosus patients
Borba, V. C., Matos, P. G., Viana, P. R. D. S., Fernandes, A. D. R. C., Sato, E. I., & Lazaretti‐Castro, M. (2005) · Lupus · doi:10.1191/0961203305lu2154oa · Cited by 66
Anti-C1q in systemic lupus erythematosus
Stojan, G., & Petri, M. (2016) · Lupus · doi:10.1177/0961203316645205 · Cited by 64
Self-citationPodocyte Injury and Glomerulosclerosis in Hyperhomocysteinemic Rats
Yi, F., SANTOS, E. A. D., Xia, M., Chen, Q., Li, P., & Li, N. (2007) · American Journal of Nephrology · doi:10.1159/000101471 · Cited by 63
Leffler, J., Ciacma, K., Gullstrand, B., Bengtsson, A. A., Martin, M., & Blom, A. M. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0726-y · Cited by 62
A perspective on B-cell-targeting therapy for SLE
Looney, R. J., Anolik, J. H., & Sanz, I. (2009) · Modern Rheumatology · doi:10.1007/s10165-009-0213-x · Cited by 61
Vitamin D and antiphospholipid syndrome
Andréoli, L., Piantoni, S., Dall’Ara, F., Allegri, F., Meroni, P. L., & Tincani, A. (2012) · Lupus · doi:10.1177/0961203312446386 · Cited by 57
Clinic and pathophysiology of photosensitivity in lupus erythematosus
Lehmann, P., & Homey, B. (2009) · Autoimmunity Reviews · doi:10.1016/j.autrev.2008.12.012 · Cited by 56
Babary, H., Liu, X., Ayatollahi, Y., Chen, X. P., Doo, L. D., Uppaluru, L. K., Kwak, M. K., Kulaga, C., Modjinou, D. V., Olech, E., et al. (2017) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13159 · Cited by 56
Ganugula, R., Arora, M., Zou, D., Agarwal, S. K., Mohan, C., & Kumar, M. N. V. R. (2020) · Science Advances · doi:10.1126/sciadv.abb3900 · Cited by 55
Böckle, B. C., & Sepp, N. T. (2014) · Lupus · doi:10.1177/0961203314559630 · Cited by 51
Sánchez‐Guerrero, J., Fragoso-Loyo, H. E., Neuwelt, C. M., Wallace, D. J., Ginzler, E. M., Sherrer, Y., McIlwain, H. H., Freeman, P. G., Aranow, C. B., Petri, M., et al. (2005) · PubMed · Cited by 50
Self-citationTime to neuropsychiatric damage occurrence in LUMINA (LXVI): a multi-ethnic lupus cohort
González, L., Pons‐Estel, G., Zhang, J., Vilá, L., Reveille, J. D., Gs, A., & for the LUMINA study group (2009) · Lupus · doi:10.1177/0961203309104392 · Cited by 50
Budhram, A., Chu, R., Rusta‐Sallehy, S., Ioannidis, G., Denburg, J., Adachi, J., & Haaland, D. (2014) · Lupus · doi:10.1177/0961203314540967 · Cited by 50
Elevated Subclinical Double-Stranded DNA Antibodies and Future Proliferative Lupus Nephritis
Olson, S. W., Lee, J. J., Prince, L. K., Baker, T. P., Papadopoulos, P. J., Edison, J. D., & Abbott, K. C. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01910213 · Cited by 50
Treatments for Lupus Nephritis: A Systematic Review and Network Metaanalysis
Singh, J. A., Hossain, A., Kotb, A., de Oliveira, A., Mudano, A. S., Grossman, J., Winthrop, K. L., & Wells, G. A. (2016) · The Journal of Rheumatology · doi:10.3899/jrheum.160041 · Cited by 45
Lan, L., Han, F., & Chen, J. (2012) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1200057 · Cited by 42
Antimalarial Drugs: Mechanisms of Action in Autoimmune Disease and Prospects for Drug Development
Fox, R. I. (1995) · BioDrugs · doi:10.1007/bf03259287 · Cited by 41
Systemic lupus erythematosus, bone health, and osteoporosis
Edens, C., & Robinson, A. B. (2015) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000197 · Cited by 41
Ikezumi, Y., Kanno, K., Koike, H., Tomita, M., Uchiyama, M., Shimizu, F., & Kawachi, H. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00259.x · Cited by 37
Low levels of vitamin D are common in primary antiphospholipid syndrome with thrombotic disease
Piantoni, S., Andréoli, L., Allegri, F., Meroni, P. L., & Tincani, A. (2012) · Reumatismo · doi:10.4081/reumatismo.2012.307 · Cited by 35
Chang, D., Chu, S. J., Chen, H. C., Kuo, S. Y., & Lai, J. H. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.016576 · Cited by 32
Etiology and Pathogenesis of Systemic Lupus Erythematosus
Crow, M. K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-31696-5.00079-6 · Cited by 31
Park, J., Jang, W., Park, H. S., Park, K. H., Kwok, S., Park, S., & Oh, E. (2020) · Journal of International Medical Research · doi:10.1177/0300060520926882 · Cited by 26
Mitral valve prolapse in systemic lupus erythematosus patients: clinical and immunological aspects
Evangelopoulos, M., Alevizaki, M., Toumanidis, S. T., Sotou, D., Evangelopoulos, C. D., Koutras, D. A., Stamatelopoulos, S. F., & Mavrikakis, M. (2003) · Lupus · doi:10.1191/0961203303lu314oa · Cited by 25
Antifibrotic vitamin D analogs
Bonventre, J. V. (2013) · Journal of Clinical Investigation · doi:10.1172/jci72748 · Cited by 25
Ma, Z., Rp, M., & Js, M. (1992) · PubMed · Cited by 24
Sánchez-Guerrero, J., Fragoso-Loyo, H. E., Neuwelt, C. M., Wallace, D. J., Ginzler, E. M., Sherrer, Y., McIlwain, H. H., Freeman, P. G., Aranow, C. B., Petri, M. A., et al. (2008) · SUNY Digital Repository Support (State University of New York System) · Cited by 10
Self-citationXing, Z., Yu, K., Yang, H., Liu, G., Chen, N., Wang, Y., & Chen, M. (2020) · World Journal of Clinical Cases · doi:10.12998/wjcc.v8.i10.2056 · Cited by 8
Cytotoxic-Immunosuppressive Drug Treatment
Frangou, E. A., Bertsias, G. K., & Boumpas, D. T. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801917-7.00062-0 · Cited by 3
Cited by
Hoi, A., Igel, T., Mok, C. C., & Arnaud, L. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00398-2 · Cited by 399
Epstein-Barr Virus and Systemic Autoimmune Diseases
Houen, G., & Trier, N. H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.587380 · Cited by 379
Risk of autoimmune diseases in patients with COVID-19: a retrospective cohort study
Chang, R., Yen-Ting Chen, T., Wang, S.-I., Hung, Y.-M., Chen, H.-Y., & Wei, C.-C. J. (2023) · eClinicalMedicine · doi:10.1016/j.eclinm.2022.101783 · Cited by 308
Targeting sphingosine-1-phosphate signaling in immune-mediated diseases: beyond multiple sclerosis
Pérez-Jeldres, T., Alvarez-Lobos, M., & Rivera-Nieves, J. (2021) · Drugs · doi:10.1007/s40265-021-01528-8 · Cited by 197
Zhang, X., Liu, C., Yang, J., Ren, H., Zhang, J., Chen, S., Ren, J., & Zhou, L. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109155 · Cited by 8
Metadata
- Authors
- Fava, A., & Petri, M.
- Venue
- Journal of Autoimmunity
- Publisher
- Elsevier BV
- Published
- 2019-01
- Volume
- 96
- Pages
- 1-13
- ISSN
- 0896-8411 (ISSN-L)
- OpenAlex
- W2901509748
- Cited by
- 754
- References
- 233
- FWCI
- 31.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.